HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of the CD95, CD38 and TGFbeta1 during active human cytomegalovirus infection in liver transplantation.

AbstractAIM:
Human cytomegalovirus (HCMV) has highly evolved mechanisms for avoiding detection by the host immune system. The aim of this study was to analyze the expression levels of TGFbeta1, soluble form of CD95, CD95 ligand (sCD95 and sCD95L, respectively) in plasma and CD95 expression on CD3(+) cells, CD38 expression on CD8(+) cells in liver transplanted recipients with active HCMV infection.
METHODS:
Blood samples were collected from 15 liver transplanted recipients with active HCMV infection and 15 recipients without HCMV infection. CD95 expression on CD3(+) cells and CD38 expression on CD8(+) cells were quantitatively detected with two-color fluorescence activated cell sorter (FACS) analysis. Lymphocyte surface phenotypes of CD4 and CD8 were detected with FACS analysis. Plasma sCD95, sCD95L and TGFbeta1 levels were determined with enzyme linked-immuno-sorbent assay (ELISA). The results were compared with that from 15 healthy individuals.
RESULTS:
CD95 expression on CD3(+) T-cells and CD38 expression on CD8(+) cells were significantly increased in active HCMV infection group compared with that in stable group or healthy group (P<0.01). No significant difference was seen between stable group and healthy group (P>0.05). The percentages of CD4(+) T-cell and CD4/CD8 ratio in active HCMV infection group were significantly lower than the values in stable group and healthy group (P<0.05). Plasma levels of TGFbeta1 and sCD95 were significantly increased in active HCMV infection group compared to stable group and healthy group (P<0.05). In contrast, plasma levels of sCD95L in healthy group were not significantly different from that expressed in active HCMV infection group and stable group (P>0.05).
CONCLUSION:
HCMV suppress proliferation of activated T cells by apoptosis and by releasing immunosuppressive cytokine TGFbeta1. This may provide an important clue to a better understanding of the pathogenesis in liver transplanted recipients with active HCMV infection.
AuthorsYuliang Wang, Yawu Liu, Yanyan Zhang, Lin Peng, Jun Ma, Zhiqin Tang, Wei Gao, Zhijun Zhu, Zhi Yao
JournalCytokine (Cytokine) Vol. 35 Issue 3-4 Pg. 193-9 (Aug 2006) ISSN: 1043-4666 [Print] England
PMID17027281 (Publication Type: Journal Article)
Chemical References
  • Membrane Glycoproteins
  • Transforming Growth Factor beta1
  • fas Receptor
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase 1 (blood)
  • Adult
  • CD8-Positive T-Lymphocytes (immunology)
  • Case-Control Studies
  • Cytomegalovirus Infections (etiology, immunology)
  • Female
  • Humans
  • Liver Transplantation (adverse effects, immunology)
  • Male
  • Membrane Glycoproteins (blood)
  • Middle Aged
  • T-Lymphocyte Subsets (immunology)
  • Transforming Growth Factor beta1 (blood)
  • fas Receptor (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: